Results 81 to 90 of about 211,796 (270)

Predictors of early clinical response to allergen-specific immunotherapy in patients with respiratory allergies

Egyptian Journal of Chest Disease and Tuberculosis
Introduction Variations in the response to allergen immunotherapy are significant among patients. Since allergen-specific immunotherapy (AIT) is long-lasting, having a marker that can predict allergen immunotherapy responders is highly important. In this
Heba W. Abdelwahab, Marwa I. Hamed, Raed E. Ali, Tamer A. EL Sayed   +3 more
doaj   +1 more source

Navigating Oral Food Challenges in Clinical Trials to Keep the Science Moving Forward

Allergy, EarlyView.
ABSTRACT The oral food challenge (OFC) has long been the reference standard for food allergy diagnosis, as well as to confirm natural development of oral tolerance. The utilization of OFCs has significantly broadened from its role in defining disease to defining participant eligibility, individual allergen reactivity thresholds and treatment outcomes ...
Edwin H. Kim, J. Andrew Bird, Helen A. Brough, David M. Fleischer, Stacie M. Jones, Ildiko Kun, Wayne Shreffler, Claire Van Eenwyk, Brian P. Vickery, Julie Wang, Alexandra F. Santos   +10 more
wiley   +1 more source

Allergen immunotherapy in atopic dermatitis

The aim of this review is to investigate the possible role of allergen immunotherapy (AIT) for house dust mites in the treatment of atopic dermatitis in adult patients (AD).
Andrzej Bożek, Agnieszka Bogacz-Piaseczyńska   +1 more
core   +1 more source

Optimising the Diagnosis of Sesame Seed Allergy With the Basophil Activation Test

Allergy, EarlyView.
The basophil activation test (using the activation marker CD203c) was the only test able to both exclude and confirm sesame seed allergy with precision. A negative skin prick test to sesame extract or tahini and undetectable IgE to Ses i 1 could not rule out sesame seed allergy.
Ru‐Xin Foong, Irene Bartha, Holly Boyd, Andreina Marques‐Mejias, Suzana Radulovic, Marta Krawiec, Faye Harrison, Malak Eghleilib, Grammatiki Antoneria, Zainab Jama, Matthew Kwok, Vasco Claro, Cristian Ricci, Tom Marrs, Gideon Lack, George Du Toit, Alexandra F. Santos   +16 more
wiley   +1 more source

Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials

, 2010
PURPOSE OF REVIEW: IgE-mediated allergies, such as allergic rhinoconjunctivitis and asthma, have become highly prevalent, today affecting up to 35% of the population in industrialized countries.
Kundig, T M, Gabriela Senti, Thomas M Kundig, Senti, G, Freiburghaus, A U, Andreas U Freiburghaus, Freiburghaus AU, Kundig TM, Senti G   +8 more
core   +1 more source

Aluminium in Allergies and Allergen immunotherapy

, 2015
Aluminium is a hot topic in the current debate. Exposure occurs due to environmental, dietary and intentional exposure to aluminium, such as in vaccines where it was introduced in 1926.
Erika Jensen-Jarolim
core   +1 more source

Effects of Live and Heat‐Treated Bifidobacterium longum CECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double‐Blind, Placebo‐Controlled Trial

Allergy, EarlyView.
This randomized, double‐blind, placebo‐controlled trial evaluated the effects of live probiotic and HT postbiotic B. longum CECT 7347 in adults with moderate–severe allergic rhinitis. Postbiotic supplementation for 8 weeks significantly reduced CSMS and dSS, exceeding the established CSMS MCID with a 33% greater improvement, when compared to placebo ...
Ana Cardoso, Malwina Naghibi, Eric Climent, Andrea Rodenes‐Gavidia, Araceli Lamelas, Laura Llobregat, Juan Martínez‐Blanch, Daniel Friedman, Vineetha Vijayakumar, Richard Day   +9 more
wiley   +1 more source

Therapeutic vaccines for allergic disease

npj Vaccines, 2017
Allergic diseases are highly prevalent worldwide and affect all age groups, contributing to a high personal and socioeconomic burden. Treatment with an “allergy vaccine” or allergen immunotherapy aims to provide long-lasting benefits by inducing ...
Danuta Gutowska-Owsiak, Graham S. Ogg
doaj   +1 more source

Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases

Frontiers in Microbiology, 2018
Allergen-specific immunotherapy represents the only available curative approach to allergic diseases. The treatment has proven effective, but it requires repetitive administrations of allergen extracts over 3–5 years and is often associated with adverse ...
Abida Zahirović, Mojca Lunder
doaj   +1 more source

New routes of allergen immunotherapy

, 2016
Objectives: Allergen immunotherapy is the only cure for immunoglobulin E mediated type I respiratory allergies. Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are the most common treatments.
Senturk, Mehmet, Reisacher, William R., Cingi, Cemal, Sakalar, Emine Guven, Muluk, Nuray Bayar, Aricigil, Mitat, Sakarya, Engin Umut   +6 more
core   +1 more source